1. Home
  2. NEXA vs ABCL Comparison

NEXA vs ABCL Comparison

Compare NEXA & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nexa Resources S.A.

NEXA

Nexa Resources S.A.

HOLD

Current Price

$14.43

Market Cap

1.0B

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$4.11

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEXA
ABCL
Founded
1956
2012
Country
Luxembourg
Canada
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
NEXA
ABCL
Price
$14.43
$4.11
Analyst Decision
Hold
Buy
Analyst Count
5
5
Target Price
$6.20
$7.75
AVG Volume (30 Days)
843.7K
4.8M
Earning Date
02-19-2026
02-24-2026
Dividend Yield
0.76%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,839,970,000.00
$35,325,000.00
Revenue This Year
$5.51
$25.45
Revenue Next Year
$3.70
$10.07
P/E Ratio
N/A
N/A
Revenue Growth
6.95
7.17
52 Week Low
$4.44
$1.89
52 Week High
$13.87
$6.52

Technical Indicators

Market Signals
Indicator
NEXA
ABCL
Relative Strength Index (RSI) 82.77 52.05
Support Level $12.24 $3.92
Resistance Level $9.82 $4.85
Average True Range (ATR) 0.65 0.34
MACD 0.28 0.02
Stochastic Oscillator 100.00 49.95

Price Performance

Historical Comparison
NEXA
ABCL

About NEXA Nexa Resources S.A.

Nexa Resources SA is a low-cost integrated zinc producer. It produces copper, silver, and gold as byproducts. The company operates through two segments namely Mining and Smelting. Its Mining segment consists of various operating units includes mineral exploration activities and the production of zinc concentrates, copper concentrates and concentrates. The Smelting segment comprises operating units which include facilities recovering and refining zinc metal out of feed materials such as zinc concentrates or secondary feed materials. It generates maximum revenue from the Smelting segment. Geographically It has a presence in Brazil, Peru, the United States of America, Switzerland, Japan, Argentina, South Korea, Colombia, Vietnam, Malaysia and other countries.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: